Inbio Ventures

General contacts

Investor type

Founded

2013

AUM

$300 M

Location

Moscow, Moscow, Russia

Investment Ticket

$1-5 m

Investment Stage

Series B

Region of investment

North America Europe

Investor profile last updated: 21 August, 2026

Profile

Over $200m deployed in early stage biotech companies through investments and strategic deals. 360˚ knowledge of the sector.

Evolution stages: Academia, In-house Industrial R&D, Corporate VC and Business Development, Professional Regulated Public Equities Asset Management.
Top positions in venture and production biotech companies in USA, Russia, Canada, EU: Pharmstandard, Generium, Aquinox, Protagonist, Codon, Allena, Transmedics and others

Inbio ventures is looking for innovative drug discovery/development projects targeting the unmet medical needs or providing dramatic advantages over the competition globally.

Therapeutic areas of the highest priority are the following:

-Oncology

-Inflammation

-Autoimmune diseases

-Orphan genetic diseases

-Critical care

-Cell-based therapy and regenerative medicine

-Stage of development

The project, ideally, should at least have passed the in-vivo proof-of-concept (PoC), and should have a strong scientific background behind it. Management team with appropriate experience is a substantial advantage.

Industry

Pharmaceuticals Biotechnology Healthcare Services Medical Devices MedTech Technology Life Sciences

Contacts

Name

Title

Social Networks

Ilya Yasny CEO, Partner

CEO, Partner

i•••@•••

Andrey Petrov Managing Partner

Managing Partner

a•••@•••

Upgrade to see contacts

TYGwpv5P2CZznERK TYGwpv5P2CZznERK

TYGwpv5P2CZznERK

[email protected]

TYGwpv5P2CZznERK TYGwpv5P2CZznERK

TYGwpv5P2CZznERK

[email protected]

TYGwpv5P2CZznERK TYGwpv5P2CZznERK

TYGwpv5P2CZznERK

[email protected]

Investment-team contacts for Inbio Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Inbio Ventures

Is Inbio Ventures a venture capital or private equity firm?

Inbio Ventures is a venture capital firm. It backs companies at Series B, writing tickets of $1-5 m.

Where is Inbio Ventures located?

Inbio Ventures is located in Moscow, Moscow, Russia.

When was Inbio Ventures founded?

Inbio Ventures was founded in 2013.

What sectors and industries does Inbio Ventures invest in?

Inbio Ventures invests in companies and startups in Pharmaceuticals, Biotechnology, Healthcare Services, Medical Devices, MedTech, Technology, Life Sciences.

What is Inbio Ventures geographical focus of investments?

Inbio Ventures invests in companies and startups in North America, Europe.

At what stages of companies and startups does Inbio Ventures typically invest in?

Inbio Ventures invests in companies and startups at Series B.

What is the usual amount of Inbio Ventures investment?

Inbio Ventures usually invests $1-5 m on average.

What is the amount of assets of under management (AUM) for Inbio Ventures?

Inbio Ventures has around $300m assets under management.

What are the contacts of Inbio Ventures?

Inbio Ventures can be reached through its website inbio-ventures.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Inbio Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Inbio Ventures data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Inbio Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Inbio Ventures profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.